These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15219139)

  • 1. [Coxib instead of NSAID plus gastric acid inhibitor. Protection for the small intestine].
    MMW Fortschr Med; 2004 Mar; 146(13):61. PubMed ID: 15219139
    [No Abstract]   [Full Text] [Related]  

  • 2. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
    MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
    Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
    Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [NSAID therapy. Gastrointestinal risks of classic NSAID are underestimated].
    MMW Fortschr Med; 2010 May; 152(20):46-7. PubMed ID: 20552882
    [No Abstract]   [Full Text] [Related]  

  • 6. [How to reduce the risks of NSAIDs].
    Gross M
    MMW Fortschr Med; 2008 Jul; 150(28-31):50-3; quiz 54. PubMed ID: 19006892
    [No Abstract]   [Full Text] [Related]  

  • 7. Upper gastrointestinal toxicity of rofecoxib and naproxen.
    Delgado Fernández M; Zambrana García JL; Diez García F
    N Engl J Med; 2001 May; 344(18):1398; author reply 1398-9. PubMed ID: 11336056
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathogen eradication prevents gastrointestinal complications].
    MMW Fortschr Med; 2007 Oct; 149(43):58-9. PubMed ID: 17992910
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of the VIGOR study. Rofecoxib halves the complication rate].
    MMW Fortschr Med; 2001 Jun; 143(23):35. PubMed ID: 11460417
    [No Abstract]   [Full Text] [Related]  

  • 10. [The selective Cox-2 inhibition by rofecoxib reduces risk of severe gastrointestinal complications of anti-inflammatory therapy by more than 50%].
    Kellner H
    Z Gastroenterol; 2001 May; 39(5):443-5. PubMed ID: 11413920
    [No Abstract]   [Full Text] [Related]  

  • 11. [When the cardiac patient with arthritis needs aspirin and NSAID: how to protect the stomach?].
    Zeidler H
    MMW Fortschr Med; 2003 Jan; 145(5):8. PubMed ID: 12619198
    [No Abstract]   [Full Text] [Related]  

  • 12. [NSAIDs for therapy of rheumatoid arthritis. Introduction].
    Takasaki Y
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():473-6. PubMed ID: 15799402
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of arthrosis. Life threatening gastrointestinal events can be reduced].
    MMW Fortschr Med; 2001 Jun; 143(23):34-5. PubMed ID: 11460416
    [No Abstract]   [Full Text] [Related]  

  • 14. [Capsule endoscopy study of gastrointestinal tolerance. Coxibes superior to NSAID plus antacid].
    MMW Fortschr Med; 2004 Mar; 146(10):43. PubMed ID: 15347082
    [No Abstract]   [Full Text] [Related]  

  • 15. Right ballpark, wrong base: assessing safety of NSAIDs.
    Shaughnessy AF
    J Fam Pract; 2002 Jun; 51(6):538. PubMed ID: 12100777
    [No Abstract]   [Full Text] [Related]  

  • 16. Upper gastrointestinal complications related to non-steroidal anti-inflammatory drugs--what have we achieved so far?
    Wong VW; Leong RW; Chan FK
    Dig Liver Dis; 2004 Jan; 36(1):1-3. PubMed ID: 14971808
    [No Abstract]   [Full Text] [Related]  

  • 17. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
    Vergara M; Catalán M; Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsteroidal anti-inflammatory drugs, aspirin, and gastrointestinal prophylaxis: an ounce of prevention.
    Scheiman JM
    Rev Gastroenterol Disord; 2005; 5 Suppl 2():39-49. PubMed ID: 16369226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy].
    Lanas A
    Rev Gastroenterol Mex; 2004; 69(4):251-60. PubMed ID: 15765979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.